RGAA

Accessibility Statement

Established on 23/09/2025.

Loretta Biotech is committed to making its website accessible, in accordance with Article 47 of Law No. 2005-102 of February 11, 2005.
This accessibility statement applies to Loretta: www.loretta-biotech.com

Compliance status

The website has been designed with particular attention to accessibility and the readability of its content for all users. The main measures implemented include:

– Optimized color contrasts for better visibility.
– Maximum simplification of mobile ergonomics and responsive design.
– Alternative text written for all images on the site.
– Smooth navigation and the addition of call-to-action (CTA) buttons to simplify the user experience.

This commitment is part of a broader approach to accessibility, reflecting the company’s values, particularly in terms of corporate social responsibility (CSR). We are implementing all available means, within our internal expertise, to meet accessibility criteria and continuously improve the user experience.

Although we are doing our best to make the site accessible, it has not yet been audited by certified professionals. We continue to actively work towards full compliance with the RGAA.

Feedback and contact

If you are unable to access a content or service, you may contact Loretta’s Design Department to be directed to an accessible alternative or to obtain the content in another format.

Email: contact@loretta-biotech.com 
Address: 5 Bis Avenue Marcel Proust, 28 000 Chartres, France